The FDA-approved Inluriyo, an oral estrogen receptor antagonist from Eli Lilly, has shown to achieve significant improvement ...

By integrating digital tools like ePRO, we can bridge the gap between patients’ lived experiences and clinical research.

Medication safety remains one of the greatest challenges in healthcare worldwide. Despite advances in clinical practice, digital health, and ...

Phoenix PCN Luton is proud to announce that it has been named a winner at the HSJ Patient Safety Awards 2025, recognising ...

Due to a complex set of factors, long-term care facilities routinely refuse to let patients return after they are admitted to ...

Diligent Robotics co-founder Vivian Chu said her "minimum viable humanoid" robots are already helping hospital staff save ...

ERA met its co-primary endpoints; giredestrant plus everolimus demonstrated significant benefit in ITT and ESR1-mutated populations in post-CDK inhibitor setting, compared with standard of care plus ...

For decades in life sciences, pharmacovigilance (PV)—a critical reinforcer of drug safety—has been a reactive function. Its ...

Third patient in the first cohort is now advancing through protocol-defined evaluations as Company anticipates additional results from second dosing of second patient in the cohort ...

TWO outstanding nurses have been recognised for their leadership and dedication to patient care. Helen Titu, the first cardiology nurse consultant at Wrightington, Wigan and Leigh Teaching Hospitals ...

Experts say that pregnant people should not be afraid to take Tylenol, rebuking unproven claims made by the Trump ...

If the Trump administration's claim about acetaminophen use turns out to be true, then this is not fearmongering. This is a public health reckoning.